Habermeier-Muth A, Altes U, Forsyth K M, Muscholl E
Pharmakologisches Institut der Universität Mainz, Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Nov;342(5):483-9. doi: 10.1007/BF00169033.
Rabbit atria were isolated with the extrinsic right vagus and sympathetic nerves intact and perfused with Tyrode solution. Noradrenaline overflow evoked by sympathetic nerve stimulation (SNS) at 3 Hz for 3 min was determined before, during, and after vagus nerve stimulation (VNS), also at 3 Hz and for 3 min. The VNS pulses preceded the SNS pulses by 3, 100 and 233 ms. Acetylcholine overflow was determined after labelling of the transmitter stores with [14C]choline. Pirenzepine 80 nmol/l failed to alter the muscarinic inhibition of noradrenaline overflow when the vago-sympathetic impulse intervals were 3 and 233 ms. At an interval of 100 ms VNS did not significantly inhibit noradrenaline overflow in the absence of pirenzepine but produced an inhibition in the presence of the drug. When the pirenzepine concentration was varied (0.4-300 nmol/l) the largest inhibition of noradrenaline overflow was observed at 5.7 nmol/l whereas 300 nmol/l fully antagonized the inhibition. Acetylcholine overflow evoked by VNS was not altered by pirenzepine 0.4-300 nmol/l. AF-DX 116 (11-[(2[(diethylamino)methyl]-1-piperidinyl)-acetyl]-5, 11-dihydro-6H-pyrido-[2,3-b]-[1,4]benzodiazepine-6-one), an M2 receptor selective antagonist, concentration-dependently (100-800 nmol/l) inhibited the decrease of tension development elicited by VNS. At the 100 ms vago-sympathetic impulse interval noradrenaline overflow was enhanced in the presence of AF-DX 116 400 and 800 nmol/l. However, already 100 nmol/l of the drug caused a maximum (fourfold) increase of acetylcholine overflow. It is concluded that acetylcholine released onto noradrenergic nerve fibres causes a small facilitation of noradrenaline overflow at a vago-sympathetic impulse interval of 100 ms.(ABSTRACT TRUNCATED AT 250 WORDS)
将兔心房分离出来,保持右侧迷走神经和交感神经的完整性,并用台氏液灌注。在迷走神经刺激(VNS)之前、期间和之后,分别测定3Hz刺激交感神经(SNS)3分钟所诱发的去甲肾上腺素溢出,VNS刺激同样为3Hz,持续3分钟。VNS脉冲先于SNS脉冲3、100和233毫秒。在用[14C]胆碱标记递质储存后,测定乙酰胆碱溢出。当迷走-交感神经冲动间隔为3和233毫秒时,80nmol/l的哌仑西平未能改变毒蕈碱对去甲肾上腺素溢出的抑制作用。在间隔100毫秒时,在无哌仑西平的情况下VNS并未显著抑制去甲肾上腺素溢出,但在有该药物存在时则产生抑制作用。当改变哌仑西平浓度(0.4 - 300nmol/l)时,在5.7nmol/l时观察到对去甲肾上腺素溢出的最大抑制作用,而300nmol/l则完全拮抗这种抑制作用。0.4 - 300nmol/l的哌仑西平未改变VNS诱发的乙酰胆碱溢出。AF-DX 116(11-[(2[(二乙氨基)甲基]-1-哌啶基)-乙酰]-5,11-二氢-6H-吡啶并-[2,3-b]-[1,4]苯并二氮杂卓-6-酮),一种M2受体选择性拮抗剂,浓度依赖性地(100 - 800nmol/l)抑制VNS引起的张力发展降低。在100毫秒的迷走-交感神经冲动间隔时,在400和800nmol/l的AF-DX 116存在下,去甲肾上腺素溢出增加。然而,该药物100nmol/l时已导致乙酰胆碱溢出最大程度(四倍)增加。得出结论:在迷走-交感神经冲动间隔为100毫秒时,释放到去甲肾上腺素能神经纤维上的乙酰胆碱会使去甲肾上腺素溢出略有增加。(摘要截断于250字)